Colorectal Cancer Clinical Trials in Miami, FL

Colorectal Cancer Clinical Trials in Miami, FL

View the best 10 colorectal cancer medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Colorectal Cancer clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for colorectal cancer in Miami, Florida

Image of Exelixis Site #1 in Tucson, United States.

XL092

Recruiting1 awardPhase 1
This trial is testing a new drug called XL092 alone and with other cancer drugs in patients with advanced solid tumors. The goal is to see if these treatments can safely stop or slow tumor growth and help the immune system fight cancer more effectively.
Image of Local Institution in Rogers, United States.

TAS-102 +2 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing a combination of two drugs, relatlimab and nivolumab, for patients with a certain type of colorectal cancer who haven't responded to other treatments. The drugs help the immune system attack the cancer.
Image of City of Hope in Duarte, United States.

ELI-002 7P

Recruiting1 awardPhase 1 & 2
This trial is testing a new treatment called ELI-002 7P for patients with specific types of cancer. The treatment helps the immune system recognize and attack these cancer cells. ELI-002 7P targets mutations that are common in various cancers and have been studied for their role in tumor growth and resistance to treatments.
Image of Sarah Cannon Research Institute in Nashville, United States.

TC-510

CAR T-cell Therapy

Recruiting1 awardPhase 1 & 2
This trial tests TC-510, a therapy using a patient's own modified T cells to target and attack cancer cells. It is aimed at patients with cancers that are hard to treat with standard methods. The modified T cells are designed to recognize specific proteins on cancer cells and get an extra boost to kill them.
Image of Mt. Sinai Comprehensive Cancer Center in Miami Beach, United States.

AlloStim +1 More

Cancer Vaccine

Recruiting1 awardPhase 2
This trial is testing a new treatment for patients with advanced colorectal cancer who have not responded to standard chemotherapy or immunotherapy. They will receive a combination of a new immunotherapy drug called AlloSt
Image of Exelixis Clinical Site #1 in Omaha, United States.

Atezolizumab +2 More

PD-L1 Inhibitor

Recruiting2 awardsPhase 3
This trial is testing a combination of two drugs, XL092 and atezolizumab, against another treatment in patients with a specific type of colorectal cancer that has spread and not responded to standard treatments. The goal is to see if the new combination can better stop cancer growth and help the immune system fight the cancer.
Image of Carilion Clinic in Roanoke, United States.

Girentuximab

Recruiting1 awardPhase 2
This trial will look at how well an imaging scan can detect and track cancer activity in people with solid tumors.
Image of City of Hope National Medical Center in Duarte, United States.

Sotorasib +1 More

Small Molecule Drug

Recruiting2 awardsPhase 3
This trial is testing two doses of sotorasib combined with panitumumab in patients with a specific type of colorectal cancer that has not responded to other treatments. Sotorasib targets a genetic mutation in the cancer cells, while panitumumab helps the immune system attack the cancer. The goal is to see if this combination can help patients live longer without their cancer getting worse.
Image of Center for Cancer and Blood Disorders in Bethesda, United States.

Bevacizumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests a new drug, DKN-01, combined with standard chemotherapy and bevacizumab for advanced colorectal cancer patients who didn't respond to earlier treatment. The treatment works by attacking cancer cells, blocking growth signals, and cutting off their blood supply.
Image of Sarah Cannon Research Institute (SCRI) at HealthONE in Denver, United States.

Venetoclax +6 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug called aplitibart with standard chemotherapy and another drug in patients with metastatic colorectal cancer that has come back or spread. The treatment works by killing cancer cells and cutting off their nutrient supply.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.